文献速递胃肠动力与功能性疾病消化内镜消化道出血

抗血小板或抗凝治疗患者行经口内镜下肌切开术的安全性与有效性:一项国际多中心病例对照研究

Safety and effectiveness of peroral endoscopic myotomy in patients on antiplatelet or anticoagulant therapy: an international multicenter case-control study.
PubMed 文献 · Gastrointest Endosc · 2020-07-24

这项国际多中心1:1病例对照研究纳入2895例接受经口内镜下肌切开术(POEM)患者中的126例抗血栓治疗者与126例匹配对照,评估术后30天主要出血和血栓栓塞事件。抗血栓组主要出血率高于对照组(5.6% vs 0.8%,P = .03),两组各发生1例血栓栓塞事件(0.79%;P = 1.00),临床成功率相似。结论认为POEM在抗血栓治疗患者中安全有效,但主要出血风险更高。

要点

  • 抗血栓治疗患者POEM术后主要出血率高于对照(5.6% vs 0.8%,P = .03)。
  • 两组各发生1例血栓栓塞事件(0.79%;P = 1.00),无POEM相关死亡。
  • 临床成功率两组相似(91.7% vs 96%,P = .20)。

核心结论

  • POEM在抗血栓治疗患者中安全有效,但与主要出血风险升高相关。

研究设计与样本

  • 国际多中心1:1病例对照研究,在10个中心利用前瞻性维护的数据库进行。
  • 考虑纳入2019年11月前所有连续接受POEM的患者。
  • 病例为接受抗血小板和/或抗凝治疗的患者,对照为未接受抗血栓治疗者,按年龄和食管动力障碍匹配。
  • 共纳入126例病例(103例抗血小板、35例抗凝、12例两者兼有)和126例对照。

主要发现

  • 抗血栓使用者主要出血率高于对照(5.6% vs 0.8%,P = .03)。
  • 两组各发生1例血栓栓塞事件(0.79%;P = 1.00)。
  • 未观察到POEM相关死亡。
  • 临床成功率病例组91.7% vs 对照组96%(P = .20),术后GERD和技术相关结局两组相似。
  • 抗血栓药物管理存在异质性,23.8%的病例未遵循指南。

关键数值与推荐

  • 所有病例中抗凝药和氯吡格雷均暂时中断。
  • 40.5%的阿司匹林使用者继续用药,未增加出血风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 抗血栓药物管理存在异质性,23.8%的病例未遵循指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The risk of bleeding and thromboembolic events in patients undergoing peroral endoscopic myotomy (POEM) who are receiving antithrombotic therapy is unknown. Our primary aim was to assess the safety of POEM in this patient subset. Secondary outcomes were rates of clinical success, GERD, and procedure-related outcomes. METHODS: This was an international, 1:1, case-control study performed at 10 centers using prospectively maintained databases. All consecutive patients who underwent POEM before November 2019 were considered for inclusion. Cases were patients on antiplatelet and/or anticoagulant therapy. Controls not receiving antithrombotics were matched for age and esophageal motility disorder. Primary outcomes were major bleeding and thromboembolic events on postprocedural day 30. RESULTS: Of 2895 patients who underwent POEM, 126 cases (103 on antiplatelets, 35 anticoagulants, 12 both) and 126 controls were enrolled. The rate of major bleeding was higher for the antithrombotics users (5.6% vs 0.8%, P = .03). Anticoagulants and clopidogrel were temporarily interrupted in all cases. Aspirin was continued in 40.5% of users without increasing the bleeding risk. One thromboembolic event occurred in each group (0.79%; P = 1.00). No POEM-related deaths were noted. Rates of clinical success (91.7% vs 96% in controls, P = .20), postprocedural GERD, and technical-related outcomes were similar in both groups. Antithrombotic management was heterogeneous, and guidelines were not adhered to in 23.8% of cases. CONCLUSIONS: POEM is safe and effective in patients receiving antithrombotic therapy although it is associated with a greater risk of major bleeding.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Rodríguez de Santiago E, Shimamura Y, Pioche M, et al. Safety and effectiveness of peroral endoscopic myotomy in patients on antiplatelet or anticoagulant therapy: an international multicenter case-control study. Gastrointest Endosc. 2020. PMID: 32717366. doi:10.1016/j.gie.2020.07.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。